Population -806 patients were admitted for sustained VT between 1978 and 2008. Methods -The following studies were performed: recording of ECG, signal averaged ECG, Holter monitoring, exercise testing (when possible), echocardiography, right angiography in patients with right VT, coronary angiography in patients older than 40 years and electrophysiological study.
G012

LONG-CHAIN ACYLCARNITINES REGULATE IHERG WHILE MEDIUM-CHAIN ACYLCARNITINE DO NOT
Free fatty acids are the primary substrate used by the heart to generate cellular ATP. Carnitine, acylcarnitine and carnitine-transferase are essential for normal metabolism of long-chain fatty acids in heart. Some of the arrhythmias observed following an ischaemia are attributed to an accumulation of long-chain acylcarnitine into ad out the cells. It has also been observed that a deÀ ciency in a carnitine transporter, OCTN2, normally found in heart, muscle and kidney, leads to a reduced plasma carnitine and acylcarnitine level. Such pathology was associated with the occurrence of ventricular À brillation and eventually to sudden death. All these data suggest that acyl-carnitine (Acyl-CARs) can regulate ion channels.
We studied the effects of different acyl-CARs at different concentrations on the hERG channel activity (IhERG) which is known to participate to lethal arrhythmias.
HEK293 cells stably expressing hERG were studied in patch clamp. Acyl-CAR derivatives from medium -(C8 and C10) and long-chain (C16 and C18:1) fatty acids were applied intra-and extracellularly at different concentrations.
C8-CAR and C10-CAR had no effect at 3 õm and 30 õm whether they are applied intra-or extracellularly. C16-CAR and C18-CAR had no effect on the current when applied intracellularly. Extracellularly, 3 õm C16-CAR or C18-CAR induced an increase of the current amplitude associated with different effects on the activation and availability properties. At this concentration, the long-chain acyl-CAR induced also a speeding of deactivation kinetic.
Long-chain acyl-CARs, but not medium-chain, regulate extracellularly IhERG. When their level varies during diseases like primary systemic carnitine deÀ ciency or ischaemia, there must be an impact on the action potential which can explain some of the cardiac arrhythmias observed. Résultats -Un ECG avec un aspect de Brugada de type 1 a été identiÀ é chez 7 patients, soit une prévalence 80 fois plus élevée que dans la population générale. Le séquençage de SCN5A était normal chez tous les patients. Un patient a fait une mort subite en rapport avec une À brillation ventriculaire et la stimulation ventriculaire programmée a déclenché des tachycardies ventriculaires polymorphes chez 5 patients.
G013
PRÉVALENCE ÉLEVÉE DU SYNDROME DE BRUGADA CHEZ LES PATIENTS ATTEINTS DE MALADIE DE STEINERT
Conlusion -La prévalence du syndrome de Brugada est plus élevée chez les patients DM1 que dans la population générale. Les patients présentant l'association de ces deux anomalies semblent exposés à un risque élevé d'arythmies ventriculaires sévères.
G014
IDENTIFICATION OF INTERSTITIAL CELLS OF CAJAL IN HUMAN PULMONARY VEINS
Introduction -The major determinant of atrial À brillation initiation is focal À ring within the muscular portion of the pulmonary veins. We hypothesized that Interstitial Cajal cells, a known type of pace-maker cells, could underlie the pace-making activity of isolated pulmonary veins.
Objective -The aim of the study was to characterize the presence and the distribution of Interstitial Cajal cells (ICC) in human pulmonary veins.
Materials and Method -Immunohistochemistry was performed on a transversal section of pulmonary vein of 8 adult human hearts obtained at autopsy from January 2005 to December 2005. Atrial À brillation history was documented in 2 out of these 8 patients. Two immunostainings were performed on successive sections to differentiate ICC from mast cells (antibody cKit and antibody AA1). Morphological and distribution analysis were performed manually and automatically. Electron microscopy and immunostaining with HCN4 and smooth muscle alpha-actin antibodies were also used to further characterized Cajal cells.
Interpretation -ICC were found in the PV sections of 3 of the 8 patients and were mainly identiÀ ed in sections with thick muscular sleeve. Two of these 3 patients had AF history. The mean distribution density of these cells was 0.6 ICC per 3 mm² with the highest density reaching 14.6 ICC per 3 mm² in a pulmonary vein of a patient with atrial À brillation history. A positive immunostaining of Cajal Cells with HCN4 was also demonstrated.
Demonstration of the close contact of the cytoplasmic process with cells around particularly with muscular cells of the atrial muscular sleeve which extend in the circumference of the pulmonary vein.
Conclusion -Interstitial Cajal cells may be detected in human pulmonary veins, particularly in patients with atrial À brillation. Given the electrophysiological attributes of these cells, their role as AF triggers deserves to be more documented. The physiology of cardiac muscle in thoracic veins is of interest as a source of ectopic activity which can lead to paroxystic atrial À brillation (Haissaguerre et al. 1998 N Engl J Med 339: 659-666 ; Chen et al. 1999 Circulation 100:1879 -1886 . We have shown that noradrenalin can induce automatic ectopic activity in the pulmonary vein of the rat (Maupoil et al. 2007 Br J Pharmacol 150:899-905 ). Here we describe the effects of adrenergic agonists upon the resting membrane potential recorded with intracellular microelectrodes from cardiac muscle in the left atrium (LA), pulmonary veins (PV) and superior vena cava (SVC) of the rat. Isolated tissues were continuously perfused with Krebs-Heinseleit solution aerated with 95 % O2, 5 % CO2 and maintained at 36-37 °C.
G015
ADRENERGIC REGULATION OF THE RESTING MEMBRANE POTENTIAL IN THE LEFT ATRIUM AND THORACIC VEINS OF THE RAT
The quiescent resting membrane potentials were: LA -84±1 mV (n=14), SVC -74±1 mV (n=14), PV -69±1 mV (n=17). In each tissue noradrenalin (10-5M) induced a biphasic response with an initial hyperpolarisation (LA -3±1 mV, SVC -9±1 mV, PV -8±1 mV) followed by a depolarisation (LA +1±2 mV, SVC +15±2 mV, PV +34±1 mV). Only in PV did noradrenalin induce automatic electrical activity when the membrane potential reached ~-50 mV.
The α-adrenergic agonist cirazoline (10-6M) induced a monophasic depolarisation of the resting membrane potential in each tissue: to -80±2 mV in LA, to -49±1 mV in SVC and to -34±1 mV in PV. In no case did cirazoline induce automatic electrical activity.
The β-adrenergic agonist isoprenaline (10-7M) induced a monophasic hyperpolarisation of the resting membrane potential in each tissue: to -87±1 mV in LA, to -79±2 mV in SVC and to -80±2 mV in PV.
Conclusions -1. There are signiÀ cant differences between the resting membrane potentials of the left atrium and both thoracic veins.
2. The responses of the resting membrane potential to adrenergic stimulation are qualitatively similar but quantitatively different with LA < SVC < PV.
3. Depolarisation is not sufÀ cient to induce automatic electrical activity. 
G016
L'ANGIOTENSINE II ET LE TNF<ALPHA> SONT DES MÉDIATEURS DU REMODELAGE DES CANAUX POTASSIQUES DÉPENDANT DE L'ATP DANS LA DÉFAILLANCE CARDIAQUE
